Evaluating patient perceptions of telemedicine quality in neuro-oncology
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
This study looks at how patients with brain tumors feel about the quality of care they get through telemedicine compared to in-person visits to see if there are any differences.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT04988009 on ClinicalTrials.gov |
What this trial studies
This observational study assesses how patients with central nervous system cancers perceive the quality of care they receive through telemedicine compared to in-person visits. It involves administering surveys to patients and reviewing their medical charts to gather data on various aspects of care delivery. The study aims to characterize differences in visit types, time spent, and the frequency of acute care sought after telemedicine encounters. By understanding these perceptions, the study seeks to improve telemedicine practices in neuro-oncology.
Who should consider this trial
Good fit: Ideal candidates include established patients with central nervous system tumors who have follow-up encounters at the Brain and Spine Center.
Not a fit: Patients who are new consults or those requiring language translation support may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the delivery of telemedicine services for patients with brain cancer, leading to improved patient satisfaction and care outcomes.
How similar studies have performed: Other studies have shown promising results in evaluating telemedicine in various fields, suggesting potential for success in this approach within neuro-oncology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease * Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be * An in-person visit * A telemedicine appointment Exclusion Criteria: * Encounter occurred with the assistance of official language translation support * Patients with telephone encounters (without interactive video) * New patient or consult visits * Neither patient nor caregiver present during the visit are available or able to answer survey questions
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Barbara J O'Brien, MD — M.D. Anderson Cancer Center
- Study coordinator: Barbara J O'Brien, MD
- Email: bjobrien@mdanderson.org
- Phone: 713-794-4380
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.